Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Antibody Fragments Market: By Product Type fragment, F2 fragment), By Application and Region Forecast 2019-2030
Antibody Fragments Market: By Product Type fragment, F2 fragment), By Application and Region Forecast 2019-2030
Antibody Fragments Market size was valued at US$ 16,450.0 million in 2023 and is poised to grow at a CAGR of 8.7% from 2024-2030. Due to increase in prevalence of various types of cancer, immunodeficiency disorders, and other infectious diseases. Antibody fragments are parts of full-length antibodies that have been digested by papain or pepsin. The market is still in its early phases, and the majority of current antibody fragments research is focused on cancer and related disorders. Moreover, rise in global geriatric population, wide range of applications with the antibody fragments, and rise in R&D activities for the development of antibody fragments are the major factors that are driving the growth of the market over the forecast timeframe.
This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. Global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). The market for antibody fragments is being pushed by the rising prevalence of target diseases, the benefits of antibody fragments over full-length antibodies, and increased R&D spending. The tight regulatory standards for the approval of antibody fragments, as well as challenges in the purification of antibody fragments, are projected to stifle market expansion.
Study Period
2024-2030Base Year
2023CAGR
8.7%Largest Market
North AmericaFastest Growing Market
Europe
Increase in the prevalence of cancer, immunodeficiency disorders, and infectious diseases is a key factor drive the global antibody fragments market. According to World Health Organization 2018, approximately 9.6 Mn death occurred due to cancer around the globe.
moreover, product approval by the FDA for antibodies fragment, raise in funding for the R&D activities by public and private sectors are anticipated to propel the global market over the forecast years.
North America accounted for larger revenue share in global antibody fragments market with significant CAGR. Increase in prevalence of cancer and other infectious diseases, rise in R&D activities for the development of antibody fragments, and rise in awareness about the antibody fragments among the healthcare professionals in U.S. and Canada are anticipated to propel the market.
Europe market projected to grow at significant rate owing to increase in research and development on new products in the market for infectious disease treatment, favorable reimbursement policies, and increase in healthcare expenditure are expected to enhance the market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 16,450.0 million |
|
Market CAGR |
8.7% |
|
By Product Type |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The global antibody fragments market size was valued at US$ 16,450.0 million in 2023 and is expected to grow at a CAGR of 8.7% from 2024 to 2030.
The antibody fragments market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The antibody fragments market key players are: Bristol-Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland)
| 1. Executive Summary |
| 2. Global Antibody Fragments Market Introduction |
| 2.1.Global Antibody Fragments Market - Taxonomy |
| 2.2.Global Antibody Fragments Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.Region |
| 3. Global Antibody Fragments Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Antibody Fragments Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Antibody Fragments Market By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. F(ab) fragment |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. F(ab)2 fragment |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Antibody Fragments Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Cancer |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Immunodeficiency Disorders |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Antibody Fragments Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Antibody Fragments Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.F(ab) fragment |
| 8.1.2.F(ab)2 fragment |
| 8.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9. Europe Antibody Fragments Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.F(ab) fragment |
| 9.1.2.F(ab)2 fragment |
| 9.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Cancer |
| 9.2.2.Immunodeficiency Disorders |
| 9.2.3.Others |
| 9.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10. Asia Pacific (APAC) Antibody Fragments Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.F(ab) fragment |
| 10.1.2.F(ab)2 fragment |
| 10.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Cancer |
| 10.2.2.Immunodeficiency Disorders |
| 10.2.3.Others |
| 10.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11. Middle East and Africa (MEA) Antibody Fragments Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.F(ab) fragment |
| 11.1.2.F(ab)2 fragment |
| 11.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Cancer |
| 11.2.2.Immunodeficiency Disorders |
| 11.2.3.Others |
| 11.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12. Latin America Antibody Fragments Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.F(ab) fragment |
| 12.1.2.F(ab)2 fragment |
| 12.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Cancer |
| 12.2.2.Immunodeficiency Disorders |
| 12.2.3.Others |
| 12.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Bristol-Myers Squibb Company (U.S.) |
| 13.2.2.Eli Lilly and Company (U.S.) |
| 13.2.3.F. Hoffmann-La Roche Ltd. (Switzerland) |
| 13.2.4.Novartis AG (Switzerland) |
| 13.2.5.Johnson & Johnson Services, Inc. (U.S.) |
| 13.2.6.Amgen, Inc. (U.S.) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.